// AMINO Acids – The building blocks of life produced by us

AMINO GmbH

Amino acids are the essential building blocks of life. They are found in all living beings, are involved in numerous metabolic processes and serve to build up new body tissue. The AMINO GmbH stands for innovative, high-quality manufactured products, which are delivered internationally to meet the needs of our customers. At our site in Frellstedt we produce daily pure amino acids and develop solutions to satisfy highest demands.

 

// Current News

AMINO invests in its future: Grand Opening of the new innovation center
Press

After a construction period of 10 months and an investment volume of EUR 4.4 million, the new innovation center was inaugurated on 11.09.2019.

> Read more

After a construction period of 10 months and an investment volume of EUR 4.4 million, the new innovation center was inaugurated on 11.09.2019.

With the construction of the innovation center and the associated expansion of its research and development activities, AMINO intends to supplement the core business of the production of pharmaceutical amino acids with amino acid derivatives and other APIs as well as developing new technologies for the company.

"We offer our customers new development resources for joint projects," adds Kai-Philipp Thomas, Sales Manager of AMINO GmbH. The new building creates ideal conditions for the development of processes and technologies such as chemical synthesis or derivatization in combination with modern analysis methods. In the future projects which are currently being processed on a laboratory scale, can be scaled up to the pilot scale and then gradually transferred into the production. "The opening of our innovation center is an integral step of completing our growth strategy," explains Dr. Lutz Thomas, Managing Director of AMINO GmbH, after the successful opening ceremony.

Picture of the new innovation center of AMINO> Show less
AMINO with new logo: Values of the company move into the centre of the brand
Press

At the same time as the opening of the new Innovation Centre, the AMINO brand was sharpened and refined as part of a new communication strategy.

> Read more

At the same time as the opening of the new Innovation Centre, the AMINO brand was sharpened and refined as part of a new communication strategy.

The modern logo symbolically combines the values of the company with the function of amino acids as the building blocks of life.

The six corporate values are thus reflected in the colour scheme of the logo. Each colour symbolises one of these values on which AMINO's self-image is based: Integrity, performance, communication, respect, responsibility and sustainability.

Graphic of Amino's corporate values and new logo.> Show less
AMINO shows its sportive side during 11th HYGIA Company Run
Employees

For the first time AMINO participated in the HYGIA Company Run in Brunswick on the August 21st 2019.

> Read more

For the first time AMINO participated in the HYGIA Company Run in Brunswick on the August 21st 2019.

A team of 19 runners strived for its best on the 5 km track in and around Brunswick’s Eintracht Arena.

Besides the athletic performance, the focus was on fun and the joint running experience.
After the race everyone agreed: "We will be back next year!"

Picture of the 11th HYGIA company run> Show less
Kai-Philipp Thomas appointed as Managing Director of AMixCo Premix GmbH
Employees

Kai-Philipp Thomas was appointed as additional Managing Director of AMixCo Premix GmbH on July 10th, 2019.

> Read more

Kai-Philipp Thomas was appointed as additional Managing Director of AMixCo Premix GmbH on July 10th, 2019.

The company, which as a subsidiary of Amino GmbH is specialized in marketing amino acid premixes, is now being managed by Dr. Lutz Thomas and Kai-Philipp Thomas.
In addition to his new position as Managing Director of AMixCo Premix GmbH, Kai-Philipp Thomas has been granted collective power of attorney as part of his activities as Head of Sales & Marketing at Amino GmbH.

> Show less
AMINO received recertification from EcoVadis for sustainable business
Press

EcoVadis is an independent platform for CSR reviews, on which companies can register the measures they take to implement corporate responsibility and have them reviewed.

> Read more

EcoVadis is an independent platform for CSR reviews, on which companies can register the measures they take to implement corporate responsibility and have them reviewed.

“We are pleased by the positive recognition of our efforts to demonstrate sustainability and are motivated and committed to improve further” emphasizes Dr. Lutz Thomas, CEO of AMINO GmbH, the company’s future goals.

Picture of the EcoVadis Silver Medal> Show less
AMINO invests in a new innovation center
Press

With the construction of a new innovation center AMINO sets the foundation for the next generation of products and services.

> Read more

With the construction of a new innovation center AMINO sets the foundation for the next generation of products and services.

“In parallel to our existing business, i.e. the production of pharmaceutical- grade amino acids, we intend to develop amino acid derivatives and other APIs as well as diversify our production technology”, says Roman Erath, project manager of the new innovation center. “Furthermore we offer our customers development resources for joint projects”, explains Kai-Philipp Thomas, head of marketing & sales, the reasons for the strategic investment.

The construction of the research and development center for approximately € 4.2 Mio is partially co-funded by the NBank to support small and medium-sized enterprises. The new facility will provide ideal conditions for the development of technologies currently not available to AMINO, such as chemical synthesis and derivatization in combination with state-of-the-art methods of analysis. At present projects are underway in a laboratory scale. In the future those projects will be up-scaled to a pilot scale and successively transferred into production. The new innovation center creates a motivating environment for young scientific and technical talents to start their professional career.

“The AminoVation-Team is responsible for the design of the new center and organizes its workplace at their own discretion” outlines CEO Dr. Lutz Thomas an additional positive effect for the Company.

Picture of the new AMINO Innovation Center(photo: Team AminoVation, f.l.t.r.: Dr. Susanne Baumgarten, Roman Erath, Dr. Alexander Rath, Michael Marx)> Show less
AMINO receives a grant of EUR 1.8 Mio for the expansion of its site
Press

Great news for AMINO: The state of Lower Saxony, the Federal Government and the European Regional Development Fund have decided to grant financial support in the amount of EUR 1.8 Mio for the expansion of the company’s operational infrastructure and its utilities.

> Read more

Great news for AMINO: The state of Lower Saxony, the Federal Government and the European Regional Development Fund have decided to grant financial support in the amount of EUR 1.8 Mio for the expansion of the company’s operational infrastructure and its utilities.

The Investment and Development Bank of Lower Saxony (NBank) thereby rewards the company’s commitment to invest into its facilities in Frellstedt in the district of Helmstedt. Within the next years AMINO plans to make an investment of EUR 9 Mio targeted at the construction of a research & development centre and the modernization of the site’s utilities infrastructure. The goal of the company is - according to Managing Director Dr. Lutz Thomas - to further increase the innovative power of the company and to strengthen the operations for the future.

> Show less
Dr. Lutz Thomas voted finalist for the employer reward „Unternehmerpreis der Region 38“
Employees

On the 6th of September 2018 the employer award, named “Unternehmerpreis der Region 38”, was given to outstanding personalities for their entrepreneurial success.

> Read more

On the 6th of September 2018 the employer award, named “Unternehmerpreis der Region 38”, was given to outstanding personalities for their entrepreneurial success.

Dr. Lutz Thomas, Managing Director of AMINO, was nominated as one of the four finalists. He was awarded with one of the prices for his dedication, his innovative ideas and exemplary business management as well as his commitment in the region by a selected committee. “It was important to me not only to strengthen our company but to support the region of its headquarter as well.” said Dr. Lutz Thomas, who was delighted by the recognition. “We will continue to do so by investing 9 million Euro within the next 3 years into a new research- & development centre and into the renovation of the company’s infrastructure to sustain its future.”

Photo of Dr. Lutz Thomas voted finalist for the employer reward „Unternehmerpreis der Region 38“Dr. Lutz Thomas, Managing Director - foto: Magnus Kleine-Tebbe> Show less
AMINO and Hufort agree on cooperation
Press

AMINO and Hufort Healthcare Pvt. Ltd. have entered a new cooperation by signing a distribution and agency agreement.

> Read more

AMINO and Hufort Healthcare Pvt. Ltd. have entered a new cooperation by signing a distribution and agency agreement.

Hufort, headquartered in Mumbay (India), specializes in the distribution and registration of active pharmaceutical ingredients. Hufort shall market, sell and distribute APIs manufactured by AMINO to Indian pharmaceutical customers.
“Working with Hufort Healthcare we allow us to access the Indian market, which holds an enormous potential for our company” says Dr. Shahid Iqbal Awan – the regional sales representative.

> Show less
AMINO considers strategic partnership for D-amino acids
Press

The AMINO GmbH reviews a strategic partnership with MH2 Biochemical Co., Ltd (Korea).

> Read more

The AMINO GmbH reviews a strategic partnership with MH2 Biochemical Co., Ltd (Korea).

The South Korean company, founded in 2003, is a manufacturer of biochemical products focusing on D-amino acids and supplying customers within the health and cosmetic sector. Through a cooperation with MH2 AMINO aims to expand its product offering in order to promote its international growth strategy. “First we have to carry out negotiations with MH2 to see how a cooperation between the two companies could work,” says Dr. Lutz, Thomas, CEO of AMINO.
“In any event we are interested in integrating new products and technologies into our range of products and services.”

> Show less
AMINO is awarded as innovative company
Press

The AMINO GmbH was awarded by the German Stifterverband with the certificate “Innovative through Research” for its research and development activities.

> Read more

The AMINO GmbH was awarded by the German Stifterverband with the certificate “Innovative through Research” for its research and development activities. The association collects regularly R & D data in order to identify the innovation power of German companies in order to develop appropriate development programs. “Our AminoVation-team develops new products and sustainable processes for the company.” explains Dr. Lutz Thomas, CEO of AMINO GmbH. “As an innovative company we are happy about the appreciation.”

Photo of the seal of quality as an innovative company> Show less
AMINO Korea Co. Ltd – the new subsidiary
Press

AMINO GmbH announces that a new subsidiary was established under the name of Amino Korea Co., Ltd.

> Read more

AMINO GmbH announces that a new subsidiary was established under the name of Amino Korea Co., Ltd. The registration of Amino Korea was executed and authorized in Seoul as of July 4, 2018. "Through this subsidiary, we aim to expand our pharmaceutical-grade amino acids business in Asia by enhancing partnerships with customers and suppliers in a timely and sustainable manner to accelerate our international growth strategy" said Dr. Lutz Thomas, CEO of AMINO GmbH.

> Show less
Amino Acids successfully registered in the Ukraine
Press

Together with its distribution partner IMCoPharma (Bílovec, Czech Republic) AMINO has successfully registered amino acids with the Ukrainian ministry for health.

> Read more

Together with its distribution partner IMCoPharma (Bílovec, Czech Republic) AMINO has successfully registered amino acids with the Ukrainian ministry for health.

The registration in Kiev enables AMINO to sell the amino acids in the Ukraine for pharmaceutical applications.
Dr. Lutz Thomas, CEO of AMINO, is pleased about the successful registration of the products and states: “Our strategy involves the international expansion of our target markets and this marks a big step in the right direction. Furthermore this strengthens our relationship with IMCoPharma.”

> Show less
AMixCo Premix GmbH "stirs up" the Amino Acid Market!
Press

AMINO is pleased to announce the foundation of AMixCo Premix GmbH dedicated to entering the market of amino acid premixes.

> Read more

AMINO is pleased to announce the foundation of AMixCo Premix GmbH dedicated to entering the market of amino acid premixes.

As a manufacturer of premixes from active pharmaceutical or nutritional ingredients, AMixCo ensures the optimal composition of amino acids in various pharmaceutical and dietetic products.

Under the AMixCo brand amino acid premixes of a high quality and with a high reliability in tailor-made formulations will be offered. Customer-specific packaging and formulation are core competencies that form an integral part of the offer that AmixCo brings to its customers.

"The new positioning of AMixCo means an extension of our products and services repertoire for our customers and builds on the established market and production expertise of Amino GmbH to fulfill the specific requests of our customers," explains Project Manager Alexander Rath.


Please visit our homepage and contact us!

www.amixco.de/en

> Show less
AMINO Manufactures L-Histidine from Fermentation
Press

AMINO offers L-histidine based on non-animal raw materials.

> Read more

AMINO offers L-histidine based on non-animal raw materials.

The existing portfolio of fermentation products is consequently upgraded by L-histidine. “This addition to our product range steadily strengthens our business portfolio and we are just a few steps away from completing the range of amino acids from our own production“, comments Dr. Lutz Thomas, Managing Director of AMINO GmbH.

The semi-essential amino acid L-histidine possesses, thanks to the imidazole ring, aromatic properties whose central role in enzyme catalysis is of metabolic importance. As a component of hemoglobin L-histidine is responsible for the formation of red blood cells and therefore for the support of oxygen transport. In pharmaceutical applications, L-histidine is e.g. used as a component for infusion solutions. Because of L-histidine primarily having to be feed to infants, it is widely used in infant formula and in dietetic products.

> Show less
AMINO received Gold award from EcoVadis for sustainable business
Press

AMINO received the Gold award and is therefore part of the top five percent of all companies rated by Eco Vadis.

> Read more

AMINO received the Gold award and is therefore part of the top five percent of all companies rated by Eco Vadis.

EcoVadis is an independent platform for CSR reviews, on which companies can register the measures they take to implement corporate responsibility and have them reviewed.

“We are pleased with the positive recognition of our efforts to be sustainable and feel motivated and committed to improve further” says Kathrin Ebers, sustainability agent at AMINO GmbH, when asked about the company’s future goals.

> Show less
AMINO receives the CEP-Certificate for L-Tyrosine from Fermentation
Press

AMINO has been granted the Certificate of Suitability (CEP) for the production of L-tyrosine from fermentation by the European Directorate for the Quality of Medicines (EDQM).

> Read more

AMINO has been granted the Certificate of Suitability (CEP) for the production of L-tyrosine from fermentation by the European Directorate for the Quality of Medicines (EDQM).

AMINO is pleased that the certification of tyrosine derived from a fermentative manufacturing process expands the product portfolio of semi-essential amino acids. „The growth of our range for amino acids by tyrosine is an important step towards our growth plans” comments Dr. Lutz Thomas, Managing Director of AMINO GmbH.

With that authorization it is possible for AMINO, that focuses on the safe and effective production of pharmaceutical and nutritional substances, to expand the product portfolio at the amino acid market, especially for tyrosine and its derivatives.

> Show less
CEP for L-Arginine
Press

AMINO has been granted the Certificate of Suitability (CEP) for the production of L-arginine by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

> Read more

AMINO has been granted the Certificate of Suitability (CEP) for the production of L-arginine by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

“We are pleased to expand our portfolio for amino acids from fermentation for regulated pharmaceutical applications by receiving the CEP for L-arginine”, states Kai-Philipp Thomas, responsible for Regulatory Affairs at AMINO. “L-arginine, a semi-essential amino acid, is a mandatory component of pharmaceutical and specialty nutrition products and hence a strategically important addition to our product spectrum”, adds Dr. Lutz Thomas, Managing Director of AMINO GmbH.

> Show less
Expansion of CEP-Portfolio
Press

AMINO has been granted a Certificate of Suitability (CEP) for the production of L-histidine by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

> Read more

AMINO has been granted a Certificate of Suitability (CEP) for the production of L-histidine by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

“We are pleased to expand our portfolio for regulated pharmaceutical applications”, states Kai-Philipp Thomas, responsible for Regulatory Affairs at AMINO. “Histidine is one of the increasingly important amino acid of our broad product spectrum, hence we are very pleased that it is now CEP certified”, adds Dr. Lutz Thomas, Managing Director of AMINO GmbH.

L-histidine is a semi-essential amino acid and is used in many pharmaceutical products and infant formula.

> Show less
Expansion of Product Portfolio is proceeding
Press

Amino has been granted the Certificate of Suitability (CEP) for the production of L-Lysine Acetate by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

> Read more

Amino has been granted the Certificate of Suitability (CEP) for the production of L-Lysine Acetate by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

“We are pleased that we can now add the first amino acid salt to our product portfolio for regulated pharmaceutical applications.”, states Kai-Philipp Thomas, responsible for Regulatory Affairs at AMINO. “With this step we have succeeded the expansion of our product portfolio by amino acid derivatives.”, adds Michael Marx, Project Manager of the AMINOVATION-Team (www.aminovation.de).

L-Lysine is an essential amino acid, but is because of its poor stability as free base difficult to access for the human body. Therefore in many pharmaceutical and nutritional products the salts of L-lysine are used like L-lysine acetate. Due to the higher stability of L-lysine acetate the bioavailability of L-lysine rises.

> Show less

// Your advantages / From fast deliveries to service

// Fast deliveries

Thanks to our large network, we can supply you as our customer just in time.

// Flexibility

We develop individual concept solutions for you, tailored to your needs.

// Sustainability

Acting ecologically and socially responsible is a matter of course for us.

// Quality

Quality is a cornerstones of the AMINO GmbH – for all products and processes.

// Comprehensive Service

Our experts support you along the entire value chain up to the final approval.

// Our Products

Adapted to your needs and the market

Amino acids are vital and indispensable for human health. We have been producing building blocks of life for our worldwide customers at our site in Frellstedt since 1958, always in first-class quality and as fast and flexible as possible.

We are continuously expanding our product range. We adapt flexibly to changes in the market – and of course to the wishes and needs of you as our customer. In addition to the classic amino acids, our portfolio also includes Betaine and other active pharmaceutical ingredients. More information about our extensive product range can be found in our product overview.

Product overview

// Brands of the Amino World

Our experts use tailor-made processes to develop innovative products and help you to solve lots of other challenges.

 

Read more

Flexibility is one of our greatest strengths. Our subsidiary AMixCo Premix GmbH develops individually composed amino acid premixes.

 

Read more

// %

Ten percent of our employees are working in the field of quality management. In this way, we are able to continuously ensure our customers that our products fulfill the highest quality requirements.

 

// %

100 percent of our products are approved exclusively by qualified personnel with the necessary experience and in accordance with the provisions of the German Medicines Act.

 

// /

We produce a wide variety of amino acids and other active ingredients in pharmaceutical quality around the clock. They are tested throughout the entire procurement and manufacturing process.

 

// %

Our company has grown by more than 400 percent in the last thirteen years. The permanent personnel increase enables us to further optimize internal processes as well as our delivery procedures.

 

// Become a part of Amino

Create the future with us

The manufacturing of innovative products requires a strong team. At AMINO, we always look for new employees, who are as passionate as we are about producing essential nutrients and active ingredients and who want to shape the future with us.

 

Whether you are experienced, a young professional, a student, school student or career changer: Be sure to find the right job in our company to play your strengths. Just click through our career section to see if there is a suitable vacancy for you. 

Up
down